Ligand validation:7THO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 7THO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7THO_NAG_B_2004	35%	49%	0.094	0.781	1.08	0.88	2	-	0	0	100%	0.9333
7THO_NAG_D_2004	4%	27%	0.137	0.508	0.63	2.29	-	3	1	0	100%	0.9333
4Z7Q_NAG_D_503	49%	73%	0.095	0.839	0.54	0.5	-	-	0	0	100%	0.9333
5HDB_NAG_B_2003	40%	85%	0.115	0.822	0.3	0.44	-	-	0	0	100%	0.9333
7UDG_NAG_D_2003	34%	70%	0.098	0.777	0.42	0.71	-	1	0	0	100%	0.9333
7UJE_NAG_B_2004	33%	77%	0.115	0.792	0.39	0.52	-	-	0	0	100%	0.9333
7TCT_NAG_B_2004	31%	75%	0.129	0.797	0.42	0.54	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_G_505	100%	86%	0.023	0.994	0.21	0.5	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.